(Q35680852)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14997175%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

review article

1 reference

title

From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14997175%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14997175%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Ana B F Emiliano

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14997175%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

language of work or name

English

0 references

publication date

1 May 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14997175%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14997175%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14997175%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14997175%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

833-846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14997175%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300412

24 November 2019

exact match

0 references

cites work

Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Bone mineral density and prolactin associations in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Thyrotropin-releasing hormone rapidly stimulates a biphasic secretion of prolactin and growth hormone in GH4C1 rat pituitary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Breast enlargement during chronic antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Opioid receptor subtypes involved in the regulation of prolactin secretion during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Low-dose citalopram as a 5-HT neuroendocrine probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Atlas of the neurons that express mRNA for the long form of the prolactin receptor in the forebrain of the female rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Control of prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Commentary. Depression and antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Hyperprolactinemic anovulatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Paroxetine and galactorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Vasopressin and oxytocin release in the brain--a synaptic event.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Cloning and expression of a rat D2 dopamine receptor cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Prolactin-Secreting Tumors and Hypogonadism in 22 Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effects of Estrogen and Progesterone on Serum and Pituitary Prolactin Levels in Ovariectomized Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Prolactin receptor mRNA localization in the hypothalamus by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Vertebral bone density in non-amenorrhoeic hyperprolactinaemic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Bone mineral density and depression: a community study in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Paraventricular nucleus lesions abolish the inhibition of feeding induced by systemic cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Prolactin receptors in the rat hypothalamus: autoradiographic localization and characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

A case of paroxetine-induced galactorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Paracrine interactions in the anterior pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Morphine and endorphins modulate dopamine turnover in rat median eminence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Neuroleptic-induced hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Differential effects of bromocriptine treatment on LH release and copulatory behavior in hyperprolactinemic male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Prolactin response to dl-fenfluramine challenge before and after treatment with paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effect of morphine on the dopamine inhibition of pituitary prolactin release in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Coexistence of tyrosine hydroxylase-like and gamma-aminobutyric acid-like immunoreactivities in neurons of the arcuate nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Fenfluramine challenge in unipolar depression with and without anger attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Evidence for a role of endorphins in stress- and suckling-induced prolactin release in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Interaction of opioid peptide-containing terminals with dopaminergic perikarya in the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

The economics of selective serotonin reuptake inhibitors in depression: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Involvement of catecholamines and glutamate in GABAergic mechanism regulatory to luteinizing hormone and prolactin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

The physiology and mechanisms of the stress-induced changes in prolactin secretion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Nonpuerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

The actions of prolactin in the brain during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Oxytocin in the central nervous system and sexual behaviour in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Stressors, including social conflict, decrease plasma prolactin in male golden hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Toward a neuroanatomy of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effects of central and peripheral type benzodiazepine ligands on thyrotropin and prolactin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

D-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Maturation of the prolactin and proopiomelanocortin-derived peptide responses to ether stress and morphine: neurochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Serotonin receptors involved in vasopressin and oxytocin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Administration of antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine attenuates ether-induced prolactin secretion in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effects of Melatonin and Serotonin on the Release of FSH and Prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Prolactin response to D-fenfluramine in outpatients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Synaptic connections between serotoninergic axon terminals and tyrosine hydroxylase-immunoreactive neurons in the arcuate nucleus of the rat hypothalamus. A combination of electron microscopic autoradiography and immunocytochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Dynamism of chemoarchitecture in the hypothalamic paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Participation of serotonin-containing neurons in the suckling-induced rise in plasma prolactin levels in lactating rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Vasoactive intestinal peptide in the hypothalamus and pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Paraventricular nucleus: a primary site mediating adrenergic stimulation of feeding and drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Prolactin-releasing activity of neurohypophysial hormones: structure-function relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effects of Serotonin Precursors and Melatonin on Serum Prolactin Release in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

HPA-Axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

The influence of academic stress and season on 24-hour concentrations of growth hormone and prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Recent studies on the role of brain peptides in control of anterior pituitary hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Vasoactive intestinal peptide-containing neurons in the paraventricular nucleus may participate in regulating prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Oestrogen, progesterone and serotonin converge on GABAergic neurones in the monkey hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Hormonal responses to fenfluramine in depressed and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Differential regulation and action of estrogen receptors alpha and beta in GH3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Interactions of dopaminergic and peptidergic factors in the control of prolactin release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Ultrastructural evidence for endogenous vasoactive intestinal peptide-like immunoreactivity in the pituitary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Distribution and characterization of prolactin binding sites in the male and female rat brain: effects of hypophysectomy and ovariectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Sequences of pituitary and placental lactogenic and growth hormones: evolution from a primordial peptide by gene reduplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effects of systemic and central prolactin injections on food intake, weight gain, and estrous cyclicity in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

The arcuate nucleus: a site for gamma-aminobutyric acid regulation of prolactin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Galactorrhea induced by paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Circadian rhythms of prolactin and thyroid-stimulating hormone during the menstrual cycle and early versus late sleep deprivation in premenstrual dysphoric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Anterior pituitary cells: getting to know their neighbors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Thyroid hormone inhibits the human prolactin gene promoter by interfering with activating protein-1 and estrogen stimulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Reversible galactorrhea and prolactin elevation related to fluoxetine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Drug-induced hyperprolactinemia: a case-non-case study from the national pharmacovigilance database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Distribution of prolactin receptor immunoreactivity in the brain of estrogen-treated, ovariectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Neuroendocrine significance of vasoactive intestinal polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Endogenous opioids mediate the nocturnal prolactin surge in the pregnant rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Evidence for a physiological role for oxytocin in the control of prolactin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Human Prolactin: 24-Hour Pattern with Increased Release during Sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Evidence for vagal involvement in the eating elicited by adrenergic stimulation of the paraventricular nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Stress Response Patterns of Plasma Corticosterone, Prolactin, and Growth Hormone in the Rat, Following Handling or Exposure to Novel Environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Suckling-induced prolactin release is suppressed by naloxone and simulated by beta-endorphin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Early steps in pituitary organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Stimulation by serotonin of vasoactive intestinal polypeptide release into rat hypophysial portal blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Estrogen modulates oxytocin gene expression in regions of the rat supraoptic and paraventricular nuclei that contain estrogen receptor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

A general overview of the anatomy of the neurohypophysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Hypothalamic Integration: Organization of the Paraventricular and Supraoptic Nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effect of thermal stress on serum prolactin, cortisol and plasma arginine vasopressin concentration in the pregnant and non-pregnant state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

New evidence of serotonin-deficient depressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

The effects of intraventricular injection of gamma-aminobutyric acid (GABA) on prolactin and gonadotropin release in conscious female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

A receptor-mediated mechanism for the transport of prolactin from blood to cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Dopamine antagonists and the development of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Neuroendocrine probes of serotonergic function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Relationship of Blood Prolactin Levels and the Risk of Subsequent Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Serum prolactin levels and their relationship to survival in women with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

Hypothalamic factors involved in the endogenous stimulatory rhythm regulating prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

The neuroendocrine response to fenfluramine in depressives and normal controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Prolactin-enhanced grooming behavior: interaction with ACTH

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Stimulation of Prolactin Secretion in Rhesus Monkeys by Vasoactive Intestinal Polypeptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Prolactin: structure, function, and regulation of secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Stimulatory Role for Brain Serotoninergic System on Prolactin Secretion in the Male Rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Galactorrhea after paroxetine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Osteoporosis in men with hyperprolactinemic hypogonadism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Pituitary lactogenic hormone concentration during pregnancy in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Midbrain microinfusions of prolactin increase the estrogen-dependent behavior, lordosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

More Fluoxetine Experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Hyperprolactinemic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Risk of Breast Cancer According to Use of Antidepressants, Phenothizaines, and Anthistamines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Serotoninergic endings on VIP-neurons in the suprachiasmatic nucleus and on ACTH-neurons in the arcuate nucleus of the rat hypothalamus. A combination of high resolution autoradiography and electron microscopic immunocytochemistry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

GALACTORRHEA DUE TO IMIPRAMINE. REPORT OF A CASE

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Effects of prolactin and estrogen deficiency in amenorrheic bone loss

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Decreased bone density in hyperprolactinemic women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Vertebral body bone mineral content in hyperprolactinemic women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Hyperprolactinemia--a significant factor in female infertility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

A prospective study of plasma prolactin levels and subsequent risk of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Lack of adverse interactions between concomitantly administered selegiline and citalopram

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Immunohistochemical localization of thyrotropin-releasing hormone in the rat hypothalamus and pituitary

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Sertraline and galactorrhea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Inhibitory effects of anti-prolactin receptor antibodies on prolactin binding in brain and prolactin-induced feeding behavior in ring doves

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Relationship Between Plasma Prolactin and the Endocrine Microenvironment of the Developing Human Antral Follicle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Effect of clozapine on human serum prolactin levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Effect of “Stress” on Serum Prolactin and Luteinizing Hormone Levels During the Estrous Cycle of the Rat1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Beta-endorphin and dynorphin participate in the stress-induced release of prolactin in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Comparison of isolated cells from liver, colon, and kidney of guinea pig.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

An inhibitory role for morphine on the release of dopamine into hypophysial portal blood and on the synthesis of dopamine in tuberoinfundibular neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

The natural history of untreated hyperprolactinemia: a prospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Bone density in amenorrheic women with and without hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Male Hyperprolactinemia: Effects on Fertility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

A modulatory role of endogenous opioids on prolactin secretion at the end of pregnancy in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Midcycle increase of prolactin seen in normal women is absent in subjects with unexplained infertility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Prolactin-Induced Mitogenesis of Lymphocytes from Ovariectomized Rats*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

GABAergic regulation of tuberoinfundibular dopaminergic neurons in the male rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Social status in pairs of male squirrel monkeys determines the behavioral response to central oxytocin administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

The proestrous surge of prolactin enhances sexual receptivity in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021

Neuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300412

7 January 2021